Bayesian Capital Management’s Corteva CTVA Stock Holding History

Bayesian Capital Management’s Portfolio CTVA Stock Details CTVA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q1	–	Sell	-57,014	Closed	-$3.25M	–	678
2024 Q4	$3.25M	Buy	57,014 +45,800	+408%	+$2.71M	0.4%	65
2024 Q3	$659K	Sell	11,214 -24,800	-69%	-$1.35M	0.08%	318
2024 Q2	$1.94M	Buy	36,014 +19,600	+119%	+$1.08M	0.22%	116
2024 Q1	$947K	Sell	16,414 -34,000	-67%	-$1.76M	0.09%	300
2023 Q4	$2.42M	Buy	+50,414	New	+$2.4M	0.26%	105
2023 Q3	–	Sell	-11,514	Closed	-$660K	–	751
2023 Q2	$660K	Buy	+11,514	New	+$672K	0.07%	347
2022 Q3	–	Sell	-5,300	Closed	-$287K	–	751
2022 Q2	$287K	Sell	5,300 -24,200	-82%	-$1.4M	0.05%	498
2022 Q1	$1.7M	Buy	+29,500	New	+$1.51M	0.25%	100
2020 Q4	–	Sell	-22,800	Closed	-$657K	–	490
2020 Q3	$657K	Buy	+22,800	New	+$642K	0.16%	166

Other funds holding CTVA

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Aristotle Capital Management Los Angeles, California $47.8B AUM 13.38% 1-Year Est. Return

Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return

IFP

Independent Franchise Partners London, United Kingdom $14.3B AUM 3.49% 1-Year Est. Return

Harris Associates Chicago, Illinois $75B AUM 11.27% 1-Year Est. Return

Bayesian Capital Management's CTVA Position: Q1 2025 in Review

Bayesian Capital Management sold out of Corteva (CTVA) in Q1 2025, closing a stake of 57,014 shares — an estimated $3.25M sold.

Bayesian Capital Management first reported a position in CTVA in Q3 2020 and held it in 9 quarters. The position peaked at $3.25M in Q4 2024. 1,322 funds tracked by Wall St. Rank hold CTVA as of Q1 2025.

Bayesian Capital Management reported no remaining Corteva position as of Q1 2025 after selling out during the quarter.
Bayesian Capital Management sold 57,014 Corteva shares in Q1 2025, an estimated $3.25M.
Bayesian Capital Management first reported a position in Corteva in Q3 2020 and held it in 9 quarters.
Bayesian Capital Management's Corteva position peaked at $3.25M in Q4 2024.
1,322 funds tracked by Wall St. Rank held Corteva as of Q1 2025.

Based on Bayesian Capital Management's 13F filing for Q1 2025, filed 15 May 2025.